Skip to main navigation

Investors
Contact

About
Investors
Investors
Shareholder Tools
Newsroom
Contact

Investor Information

AddThis Sharing Buttons

Share to LinkedIn Share to Facebook Share to Twitter

News Releases

Keyword Search

Year

May 29, 2020

Zomedica Pharmaceuticals Corp. Closes $20 Million Public Offering

May 26, 2020

Zomedica Pharmaceuticals Corp. Announces $20 Million Public Offering

May 20, 2020

Zomedica Completes Verification of Three More Assays for its TRUFORMA™ Point-of-Care Diagnostic Platform

May 11, 2020

Zomedica Announces First Quarter 2020 Financial Results

April 21, 2020

Zomedica Completes Verification of its TRUFORMA™ Point-of-Care Diagnostic Platform and the First Assay, Canine total T4

April 13, 2020

Zomedica Provides Corporate Update

April 7, 2020

Zomedica Pharmaceuticals Corp. Announces Pricing of $4.0 Million Public Offering

April 7, 2020

Zomedica Pharmaceuticals Corp. Announces Public Offering

February 26, 2020

Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results

February 14, 2020

Zomedica Announces Completion of $2.5 Million Registered Direct Offering

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Investors

Investor Overview
News Releases
Events & Presentations
Stock Information
Financial Information
Corporate Governance
Investor FAQs
Email Alerts
Contact IR

Shareholder Tools

Email Alerts
RSS Feeds
Print Page
Share This

X

LinkedIn
Facebook
Twitter

OUR VISION & MISSION

Advancing the health, effectiveness, and financial well-being of the companion animal veterinarian by delivering economically and professionally beneficial products and services.

Zomedica on LinkedIn
Zomedica on Facebook
Zomedica on Youtube
Zomedica on Twitter

© 2021 Zomedica Corp. and Zomedica Inc. All Rights Reserved.

Privacy Notice
Terms of Use
Forward Looking Statements